PUBLISHER: Persistence Market Research | PRODUCT CODE: 1742477
PUBLISHER: Persistence Market Research | PRODUCT CODE: 1742477
Gastroenterology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
Persistence Market Research has recently released a comprehensive report on the worldwide gastroenterology market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global gastroenterology market from 2025 to 2032.
Key Insights:
- Gastroenterology Market Size (2025E): USD 38.46 Billion
- Projected Market Value (2032F): USD 56.54 Billion
- Global Market Growth Rate (CAGR 2025 to 2032): 5.7%
Gastroenterology Market - Report Scope:
Gastroenterology involves the diagnosis and treatment of disorders related to the digestive system, including diseases affecting the stomach, intestines, liver, pancreas, and esophagus. The gastroenterology market caters to hospitals, specialty clinics, ambulatory surgical centers, and diagnostic laboratories, offering a wide range of products such as endoscopy devices, diagnostic tools, surgical instruments, and pharmaceuticals. Market growth is driven by the increasing prevalence of gastrointestinal disorders, rising healthcare expenditure, and technological advancements in diagnostic and therapeutic procedures that improve patient outcomes and procedural safety.
Market Growth Drivers:
The global gastroenterology market is propelled by several key factors, including the rising incidence of chronic gastrointestinal diseases such as inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and colorectal cancer. Growing awareness about early diagnosis and advanced treatment options enhances market expansion. Technological innovations, including high-definition endoscopy, capsule endoscopy, and minimally invasive surgical devices, offer improved diagnostic accuracy and reduced recovery times, fostering market growth. Moreover, increasing adoption of outpatient care and telemedicine services in gastroenterology create new opportunities for market players to extend their reach to diverse patient populations.
Market Restraints:
Despite promising growth prospects, the gastroenterology market faces challenges related to high procedural costs, limited reimbursement policies in certain regions, and the complexity of regulatory approvals for new devices and drugs. Additionally, shortage of skilled gastroenterologists and uneven access to advanced healthcare infrastructure in developing economies hinder market penetration. Addressing these barriers requires collaborative efforts between healthcare providers, manufacturers, and policymakers to ensure affordable and equitable access to gastroenterology care.
Market Opportunities:
The gastroenterology market presents significant growth opportunities driven by advancements in digital health technologies, such as AI-assisted diagnostics and remote patient monitoring, which improve treatment precision and patient engagement. Furthermore, expanding applications of biologics and targeted therapies for chronic gastrointestinal diseases broaden the therapeutic landscape. Strategic investments in research and development, partnerships with healthcare institutions, and the introduction of cost-effective, patient-friendly products are essential to capitalize on emerging opportunities and maintain competitive advantage in this dynamic market.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the gastroenterology market globally?
- Which products and procedures are driving adoption across different healthcare settings?
- How are technological advancements reshaping the competitive landscape of the gastroenterology market?
- Who are the key players contributing to the gastroenterology market, and what strategies are they employing to maintain market relevance?
- What are the emerging trends and future prospects in the global gastroenterology market?
Competitive Intelligence and Business Strategy:
These companies invest in R&D to develop advanced endoscopic devices, surgical instruments, and therapeutic drugs tailored to diverse clinical needs. Collaborations with healthcare providers, research institutions, and regulatory bodies facilitate faster market access and technology adoption. Moreover, emphasis on clinical trials, evidence-based medicine, and patient education supports market growth and enhances patient outcomes in this rapidly evolving healthcare segment.
Key Companies Profiled:
- AbbVie Inc.
- Allergan plc
- AstraZeneca plc
- Boehringer Ingelheim International GmbH
- Eisai Co., Ltd.
- GlaxoSmithKline plc
- Johnson & Johnson
- Novartis International AG
- Pfizer Inc.
- Procter & Gamble Co.
- Takeda Pharmaceutical Company Limited
Gastroenterology Market Research Segmentation:
The gastroenterology market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various gastrointestinal disorders and patient populations.
By Type
- Branded
- Generics
By Application
- Crohn's Disease
- Ulcerative Colitis
- Irritable Bowel Syndrome (IBD)
- Others
By End-user
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- South Asia and Oceania
- Latin America
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Gastroenterology Market Snapshot, 2025-2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
- 3.1. Regulatory Landscape
- 3.2. Pipeline Analysis
- 3.3. Product Adoption Analysis
- 3.4. Value Chain Analysis
- 3.5. Key Promotional Strategies by Manufacturers
- 3.6. PESTLE Analysis
- 3.7. Porter's Five Force Analysis
4. Gastroenterology Market Outlook:
- 4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
- 4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
- 4.3. Global Gastroenterology Market Outlook: Form
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Type, 2019-2024
- 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
- 4.3.3.1. Branded
- 4.3.3.2. Generics
- 4.3.4. Market Attractiveness Analysis: Type
- 4.4. Global Gastroenterology Market Outlook: Application
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
- 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 4.4.3.1. Crohn's Disease
- 4.4.3.2. Ulcerative Colitis
- 4.4.3.3. Irritable Bowel Syndrome (IBD)
- 4.4.3.4. Others
- 4.4.4. Market Attractiveness Analysis: Application
- 4.5. Global Gastroenterology Market Outlook: End-user
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2024
- 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 4.5.3.1. Retail Pharmacies
- 4.5.3.2. Hospital Pharmacies
- 4.5.3.3. Online Pharmacies
- 4.5.4. Market Attractiveness Analysis: End-user
5. Global Gastroenterology Market Outlook: Region
- 5.1. Key Highlights
- 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
- 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
- 5.4. Market Attractiveness Analysis: Region
6. North America Gastroenterology Market Outlook:
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 6.2.1. By Type
- 6.2.2. By Application
- 6.2.3. By End-user
- 6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
- 6.4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
- 6.4.1. Branded
- 6.4.2. Generics
- 6.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 6.5.1. Crohn's Disease
- 6.5.2. Ulcerative Colitis
- 6.5.3. Irritable Bowel Syndrome (IBD)
- 6.5.4. Others
- 6.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 6.6.1. Retail Pharmacies
- 6.6.2. Hospital Pharmacies
- 6.6.3. Online Pharmacies
- 6.7. Market Attractiveness Analysis
7. Europe Gastroenterology Market Outlook:
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Type
- 7.2.3. By Application
- 7.2.4. By End-user
- 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
- 7.4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
- 7.4.1. Branded
- 7.4.2. Generics
- 7.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 7.5.1. Crohn's Disease
- 7.5.2. Ulcerative Colitis
- 7.5.3. Irritable Bowel Syndrome (IBD)
- 7.5.4. Others
- 7.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 7.6.1. Retail Pharmacies
- 7.6.2. Hospital Pharmacies
- 7.6.3. Online Pharmacies
- 7.7. Market Attractiveness Analysis
8. East Asia Gastroenterology Market Outlook:
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Type
- 8.2.3. By Application
- 8.2.4. By End-user
- 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
- 8.4.1. Branded
- 8.4.2. Generics
- 8.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 8.5.1. Crohn's Disease
- 8.5.2. Ulcerative Colitis
- 8.5.3. Irritable Bowel Syndrome (IBD)
- 8.5.4. Others
- 8.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 8.6.1. Retail Pharmacies
- 8.6.2. Hospital Pharmacies
- 8.6.3. Online Pharmacies
- 8.7. Market Attractiveness Analysis
9. South Asia & Oceania Gastroenterology Market Outlook:
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Type
- 9.2.3. By Application
- 9.2.4. By End-user
- 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
- 9.4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
- 9.4.1. Branded
- 9.4.2. Generics
- 9.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 9.5.1. Crohn's Disease
- 9.5.2. Ulcerative Colitis
- 9.5.3. Irritable Bowel Syndrome (IBD)
- 9.5.4. Others
- 9.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 9.6.1. Retail Pharmacies
- 9.6.2. Hospital Pharmacies
- 9.6.3. Online Pharmacies
- 9.7. Market Attractiveness Analysis
10. Latin America Gastroenterology Market Outlook:
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Type
- 10.2.3. By Application
- 10.2.4. By End-user
- 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
- 10.4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
- 10.4.1. Branded
- 10.4.2. Generics
- 10.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 10.5.1. Crohn's Disease
- 10.5.2. Ulcerative Colitis
- 10.5.3. Irritable Bowel Syndrome (IBD)
- 10.5.4. Others
- 10.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 10.6.1. Retail Pharmacies
- 10.6.2. Hospital Pharmacies
- 10.6.3. Online Pharmacies
- 10.7. Market Attractiveness Analysis
11. Middle East & Africa Gastroenterology Market Outlook:
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Type
- 11.2.3. By Application
- 11.2.4. By End-use
- 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
- 11.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
- 11.4.1. Branded
- 11.4.2. Generics
- 11.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 11.5.1. Crohn's Disease
- 11.5.2. Ulcerative Colitis
- 11.5.3. Irritable Bowel Syndrome (IBD)
- 11.5.4. Others
- 11.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 11.6.1. Retail Pharmacies
- 11.6.2. Hospital Pharmacies
- 11.6.3. Online Pharmacies
- 11.7. Market Attractiveness Analysis
12. Competition Landscape
- 12.1. Market Share Analysis, 2025
- 12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
- 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. AbbVie Inc
- 12.3.1.1. Overview
- 12.3.1.2. Segments and Products
- 12.3.1.3. Key Financials
- 12.3.1.4. Market Developments
- 12.3.1.5. Market Strategy
- 12.3.2. Allergan plc
- 12.3.3. AstraZeneca plc
- 12.3.4. Boehringer Ingelheim International GmbH
- 12.3.5. Eisai Co., Ltd.
- 12.3.6. GlaxoSmithKline plc
- 12.3.7. Johnson & Johnson
- 12.3.8. Novartis International AG
- 12.3.9. Pfizer Inc.
- 12.3.10. Procter & Gamble Co.
- 12.3.11. Takeda Pharmaceutical Company Limited
- 12.3.1. AbbVie Inc
13. Appendix
- 13.1. Research Methodology
- 13.2. Research Assumptions
- 13.3. Acronyms and Abbreviations
